Targeting immune escape in Cluster 5 DLBCL Grant

Overview

date/time interval

September 27, 2021 - September 26, 2024

awarded by

AstraZeneca Pharmaceuticals LP

administered by

Medicine-Hematology and Medical Oncology

sponsor award ID

SRA 215352-01

Affiliation

contributor

Melnick, Ari M. Co-Principal Investigator 2021 - 2023
Sarapulov, Alexey Key Personnel 2021 - 2023
Zappasodi, Roberta Principal Investigator 2021 - 2023